title: [Second line AUO (Working Group Urological Oncology) study AB 35/09 on metastasized urothelial carcinoma. Phase II study with RAD001 in combination with paclitaxel for patients with metastasized urothelial carcinoma of the urinary bladder after failure of platinum-based chemotherapy (CRAD001)].
authors: Geschäftsstelle der AUO, MeckEvidence, Seestraße 11, Schwarz, Germany. AUO@MeckEvidence.de
authors: H
authors: H
authors: Rexer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D000068338:Everolimus; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000556:secondary*
chemical_list: D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus